Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LISATA THERAPEUTICS, INC. | 85,725 | reported | 09 Jan 2026 | tx 4+85,725 |
| Kura Oncology, Inc. | 81,000 | reported | 24 Jan 2018 | tx 5+261,000−5,596 |
| Perspective Therapeutics, Inc. | 50,000 | reported | 02 Mar 2026 | tx 7+1,078,975 |
| ANADYS PHARMACEUTICALS INC | 22,034 | reported | 12 Apr 2004 | tx 1+5,000 |
| PepGen Inc. | 16,000 | reported | 04 Jun 2025 | tx 4+52,667 |
| FS Development Corp. II | 0 | reported | 31 Aug 2023 | tx 8+441,250−999,596 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | Perspective Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 09 Jan 2026 | GRANT_AWARD | LISATA THERAPEUTICS, INC. | 30,456 | 0.00 USD | |
| 04 Jun 2025 | GRANT_AWARD | PepGen Inc. | 16,000 | 0.00 USD | deriv |
| 03 Mar 2025 | GRANT_AWARD | Perspective Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 09 Jan 2025 | GRANT_AWARD | LISATA THERAPEUTICS, INC. | 15,789 | 0.00 USD | |
| 04 Dec 2024 | PURCHASE | Perspective Therapeutics, Inc. | 25,975 | 3.85 USD | |
| 20 Jun 2024 | GRANT_AWARD | Perspective Therapeutics, Inc. | 23,000 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | PepGen Inc. | 13,000 | 0.00 USD | deriv |
| 09 Jan 2024 | GRANT_AWARD | LISATA THERAPEUTICS, INC. | 19,480 | 0.00 USD | |
| 12 Dec 2023 | GRANT_AWARD | Perspective Therapeutics, Inc. | 230,000 | 0.00 USD | deriv |
| 31 Aug 2023 | TENDER | FS Development Corp. II | 316,753 | — | |
| 31 Aug 2023 | OTHER | FS Development Corp. II | 156,250 | — | deriv |
| 31 Aug 2023 | OTHER | FS Development Corp. II | 241,593 | — | deriv |
| 31 Aug 2023 | OTHER | FS Development Corp. II | 160,000 | — | deriv |
| 31 Aug 2023 | OTHER | FS Development Corp. II | 125,000 | — | deriv |
| 22 Jun 2023 | GRANT_AWARD | PepGen Inc. | 12,000 | 0.00 USD | deriv |
| 02 Jun 2023 | GRANT_AWARD | Perspective Therapeutics, Inc. | 470,000 | 0.00 USD | deriv |
| 02 Jun 2023 | GRANT_AWARD | Perspective Therapeutics, Inc. | 230,000 | 0.00 USD | deriv |
| 01 Feb 2023 | GRANT_AWARD | FS Development Corp. II | 156,250 | 0.00 USD | deriv |
| 09 Jan 2023 | GRANT_AWARD | LISATA THERAPEUTICS, INC. | 20,000 | 0.00 USD | |
| 14 Sept 2022 | GRANT_AWARD | FS Development Corp. II | 125,000 | 0.00 USD | deriv |
| 06 May 2022 | GRANT_AWARD | PepGen Inc. | 11,667 | 0.00 USD | deriv |
| 01 Feb 2022 | GRANT_AWARD | FS Development Corp. II | 160,000 | 0.00 USD | deriv |
| 24 Jan 2018 | GRANT_AWARD | Kura Oncology, Inc. | 81,000 | 0.00 USD | deriv |
| 13 Dec 2016 | GIFT | Kura Oncology, Inc. | 2,596 | 0.00 USD |